JSR North America Holdings, Inc.

United Statesjsr-nahq.com

JSR North America Holdings, Inc. is a privately held holding company headquartered in Sunnyvale, California, United States. Established in 2019, it serves as the North American headquarters for JSR Corporation, managing and overseeing the group's operations in the region.

Read more

The company holds JSR Micro, Inc., a key provider of semiconductor materials including photoresists and other advanced chemicals essential for chip manufacturing, and JSR Life Sciences, LLC, which offers integrated drug development and manufacturing solutions for the biopharmaceutical industry, encompassing drug discovery, process development, clinical supply, and biologics production.

Through these subsidiaries and affiliates, JSR North America Holdings supports activities in semiconductor materials, life sciences, and clean energy solutions across North America, with broader reach into Europe and Asia-Pacific via JSR's global network. It provides shared administrative services such as HR, IT, accounting, and compliance to its operating companies.

As a wholly owned subsidiary of JSR Corporation, which is undergoing acquisition by Mitsui Chemicals, Inc., the entity positions JSR's North American businesses within the larger Japanese chemical and materials conglomerate. JSR is recognized as a global leader in semiconductor materials, particularly photoresists, and in life sciences technologies supporting therapeutic development.

Also known as JSR NAHQ and JSR North America Holding Company, Inc..

Projects JSR North America Holdings is involved in

None yet. When a new project in the record names JSR North America Holdings as owner, partner or investor, it shows here.

Active projects close to JSR North America Holdings

JSR North America Holdings in chemical industry news

9 November 2026
Mitsui Chemicals to acquire JSR, file shelf registration and revise B&GM split-off scope

Plans to buy JSR for ¥1.84 trillion, target closing in H2 of FY ending March 2028; DBJ to co-invest ¥200bn; shelf registration up to ¥150bn to help refinance a ¥1,640bn bridge loan.